Product NDC: | 40042-048 |
Proprietary Name: | Betamethasone Sodium Phosphate and Betamethasone Acetate |
Non Proprietary Name: | Betamethasone Sodium Phosphate and Betamethasone Acetate |
Active Ingredient(s): | 3; 3 mg/mL; mg/mL & nbsp; Betamethasone Sodium Phosphate and Betamethasone Acetate |
Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 40042-048 |
Labeler Name: | PharmaForce, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090747 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090731 |
Package NDC: | 40042-048-05 |
Package Description: | 5 mL in 1 VIAL, MULTI-DOSE (40042-048-05) |
NDC Code | 40042-048-05 |
Proprietary Name | Betamethasone Sodium Phosphate and Betamethasone Acetate |
Package Description | 5 mL in 1 VIAL, MULTI-DOSE (40042-048-05) |
Product NDC | 40042-048 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betamethasone Sodium Phosphate and Betamethasone Acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR |
Start Marketing Date | 20090731 |
Marketing Category Name | ANDA |
Labeler Name | PharmaForce, Inc. |
Substance Name | BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
Strength Number | 3; 3 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |